Resources for you and your loved ones

Information, guidance and support for your osimertinib treatment journey.

You may be looking for simple information, trusted tools and real-life stories to help you make sense of your diagnosis and get the support you need.

Start exploring the resources below – and remember that you are not alone, your healthcare team is with you at every step:

Understanding NSCLC Understanding osimertinib Practical support with osimertinib Hear from others

Understanding NSCLC

What is EGFR?

Please ensure to watch the 'Side Effects of Osimertinib' animation following this video. Renewal date: 01/04/28. If you would like to provide feedback on this material, please click here www.astrazeneca.co.uk/feedback-questionnaire.html.

Visit the Understand your lung cancer diagnosis page to learn more about your diagnosis.

Understanding osimertinib

Osimertinib with Platinum-Pemetrexed Chemotherapy

Renewal date: 01/04/28. If you would like to provide feedback on this material, please click here www.astrazeneca.co.uk/feedback-questionnaire.html.

Read now

Visit the What is osimertinib? page to understand what osimertinib is and how it works.

Practical support with osimertinib

Side effects of osimertinib

Renewal date: 01/04/28. If you would like to provide feedback on this material, please click here www.astrazeneca.co.uk/feedback-questionnaire.html.

Read now

Visit the Tips for managing side effects page for advice on how to manage side effects of your treatment.

Hear from others

Watch Natasha's story

Lung Cancer
Organisations

A helpful range of services and resources are always available

Learn more

Back
to top

GB-76794 I DOP: October 2026

This website is only intended for UK patients who have been prescribed TAGRISSO^® (osimertinib), which is indicated after surgery in adults with stage 1B-3A NSCLC with a particular EGFR mutation, and also in locally advanced or metastatic NSCLC with a particular EGFR mutation. It does not replace the Patient Information Leaflet, which you can find in the carton containing your medicine and which you should read alongside this information. If you have any questions about your treatment, talk to your healthcare team or refer to the Patient Information Leaflet.

Reporting side effects

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme, website: https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of medicines.

Side effects can also be reported to AstraZeneca in the following ways:

Online: https://contactazmedical.astrazeneca.com

Email: Medical.InformationUK@astrazeneca.com

No imagery of real patients has been used on this site.

Welcome to tagrissoandme.co.uk*